All data are based on the daily closing price as of December 10, 2025
e
Eiken Chemical
4549.TSE
15.63 USD
0.10
+0.64%
Overview
Last close
15.63 usd
Market cap
515.23M usd
52 week high
17.03 usd
52 week low
12.89 usd
Target price
13.4 usd
Valuation
P/E
20.106
Forward P/E
N/A
Price/Sales
1.9482
Price/Book Value
1.8301
Enterprise Value
471.24M usd
EV/Revenue
1.7914
EV/EBITDA
9.8266
Key financials
Revenue TTM
263.06M usd
Gross Profit TTM
106.37M usd
EBITDA TTM
34.62M usd
Earnings per Share
0.75 usd
Dividend
0.36 usd
Total assets
427.82M usd
Net debt
N/A usd
About
Eiken Chemical Co., Ltd. engages in the manufacture and sale of clinical diagnostics in Japan. It offers microbiological reagents for diagnosis of microorganism infection, such as mediums, antimicrobial susceptibility, and rapid test reagents; urinalysis test strips for occult blood, protein, and glucose; and fecal immunochemical tests reagents for screening of colorectal cancer. The company also provides immunological and serological reagents to detect and monitor infectious disease, rheumatism, inflammation, atrophic gastritis, and prostate specific antigens; and clinical chemistry tests to measure and analyze biological components in blood serum and urine. In addition, it sells reagents and devices of microbiological test for food poisoning bacteria and environmental inspection; and offers nucleic acid amplification method, as well as provides various types of automated analyzers. The company was formerly known as Nihon Eiyokagaku Co., Ltd. and changed its name to Eiken Chemical Co., Ltd. in 1969. Eiken Chemical Co., Ltd. was incorporated in 1939 and is headquartered in Tokyo, Japan.